Last update 01 Nov 2024
Tubulis GmbH

Tubulis GmbH

Holding Company|
2012|
Germany
|
10-50
|

Overview

Basic Info

Introduction
Tubulis utilizes a blend of innovative proprietary technologies and disease-specific expertise to create tailored protein-drug conjugates. Their mission is to enhance the therapeutic capabilities of antibody-drug conjugates (ADCs) by addressing limitations such as toxicity, efficacy, and indication. Through the development of novel conjugates and strategic partnerships, Tubulis aims to revolutionize the ADC landscape and improve patient outcomes.

Tags

Neoplasms
Respiratory Diseases
Hemic and Lymphatic Diseases
Antibody drug conjugate (ADC)

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Antibody drug conjugate (ADC)5

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
2
Phase 2 Clinical
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
TUB-040
( NaPi-2b )
Congenital Thrombotic Disease, Due to Protein C Deficiency
More
Phase 2 Clinical
TUB-030
( 5T4 )
Small Cell Lung Cancer
More
Phase 2 Clinical
TUB-010
( CD30 )
T-Cell Lymphoma
More
Preclinical
TUB-060
Solid tumor
More
Preclinical
TUB-050
Solid tumor
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free